Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BEAZER HOMES USA INCBZH · Entity 5036 | Director | November 17, 2025 | November 18, 2025 |
| EQUIFAX INCEFX · Entity 3235 | EVP, Chief Legal Officer | February 11, 2025 | February 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BEAZER HOMES USA INC
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,116 |
Reported balance
After 2025-11-17 transaction · row 1
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 7,199 · Balance 23,116 F1: Restricted stock award scheduled to vest on the first anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award scheduled to vest on the first anniversary of grant date.
EQUIFAX INC
Report date February 11, 2025 · Filed February 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,175 |
Last balance in matching sequence
After 2025-02-11 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-02-11 · Grant · Acquired 2,710 · Balance 17,202 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 2 · 2025-02-11 · Tax withholding · Disposed 2,027 · Balance 15,175 F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 23:13 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 7,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001562224-25-000005 · wk-form4_1763507594.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,116 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| May 09, 2025 Filed May 12, 2025 20:52 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | PurchaseCommon Stock | 10,000 | $21.50 | $215,000.00 |
DisclosureSEC source: 0000915840-25-000047 · wk-form4_1747083140.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,917 F1 · price: The price is the weighted average price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $21.33 to $21.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,027 | $253.00 | $512,831.00 |
DisclosureSEC source: 0001225208-25-001650 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,175 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001650 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,202 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 10,322 | $0.00 Strike: $252.90 | $0.00 |
DisclosureSEC source: 0001225208-25-001584 · doc4.xml · derivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,322 Underlying: Common Stock · 10,322 shares Expires 2035-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001584 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,492 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:45 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantNo securities are beneficially owned | 5,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-24-000105 · wk-form4_1732052692.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,917 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| October 25, 2024 Filed Oct 29, 2024 20:09 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,000 | $272.92 | $272,920.00 |
DisclosureSEC source: 0001225208-24-009537 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,269 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 803 | $305.91 | $245,644.85 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 6 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,259 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $305.73 to $306.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 729 | $305.14 | $222,447.64 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 5 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,062 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $304.73 to $305.70, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 593 | $302.92 | $179,629.60 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 4 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,791 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $302.61 to $303.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 484 | $307.08 | $148,624.93 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 3 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $306.73 to $307.405, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 300 | $304.30 | $91,291.17 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,868 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $303.735 to $304.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 28, 2024 Filed Aug 29, 2024 20:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 91 | $300.43 | $27,339.09 |
DisclosureSEC source: 0001225208-24-008299 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,168 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2024. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $300.39 to $300.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 07, 2024 Filed Aug 8, 2024 21:14 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantNo securities are beneficially owned | 866 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-24-000059 · wk-form4_1723151640.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 866 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| July 25, 2024 Filed Jul 30, 2024 00:32 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 5,523 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-24-007618 · doc4.xml · derivative · entry 5 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,523 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| July 25, 2024 Filed Jul 30, 2024 00:32 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,378 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-24-007618 · doc4.xml · derivative · entry 4 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,378 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| July 25, 2024 Filed Jul 30, 2024 00:32 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 8,210 | $267.56 | $2,196,667.60 |
DisclosureSEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 3 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,259 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 25, 2024 Filed Jul 30, 2024 00:32 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 4,378 | $175.48 | $768,251.44 |
DisclosureSEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 25, 2024 Filed Jul 30, 2024 00:32 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 5,523 | $191.44 | $1,057,323.12 |
DisclosureSEC source: 0001225208-24-007618 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,560 | $255.78 | $654,796.80 |
DisclosureSEC source: 0001225208-24-002070 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,546 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002070 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,106 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 8,871 | $0.00 Strike: $249.18 | $0.00 |
DisclosureSEC source: 0001225208-24-001934 · doc4.xml · derivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,871 Underlying: Common Stock · 8,871 shares Expires 2034-02-09 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001934 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,163 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,127 | $209.22 | $445,005.20 |
DisclosureSEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 5 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,394 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $208.675 to $209.635, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 655 | $208.16 | $136,343.16 |
DisclosureSEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 4 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,521 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $207.665 to $208.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 635 | $206.97 | $131,424.62 |
DisclosureSEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 3 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,176 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $206.56 to $207.345, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 358 | $209.88 | $75,138.11 |
DisclosureSEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $209.755 to $210.01, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 225 | $205.31 | $46,194.98 |
DisclosureSEC source: 0001225208-23-010349 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $204.94 to $205.65, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 19,172 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · derivative · entry 13 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,172 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 15,899 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · derivative · entry 12 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,899 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 13,150 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · derivative · entry 11 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,150 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 506 | $201.56 | $101,987.39 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 10 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,394 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F9 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.54 to $201.56, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 13,123 | $200.97 | $2,637,335.87 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 9 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.51 to $201.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 5,365 | $199.91 | $1,072,498.91 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 8 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.51 to $200.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 23,803 | $198.96 | $4,735,780.61 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 7 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,388 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.49 to $199.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 4,266 | $198.27 | $845,818.97 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 6 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,191 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.47 to $198.465, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 753 | $196.88 | $148,246.95 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 5 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,457 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.44 to $197.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 405 | $195.35 | $79,116.10 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 4 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,210 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $195.02 to $195.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 19,172 | $149.53 | $2,866,789.16 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 3 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 15,899 | $138.45 | $2,201,216.55 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:06 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 13,150 | $127.37 | $1,674,915.50 |
DisclosureSEC source: 0001062993-23-021103 · form4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,930 | $203.81 | $597,163.30 |
DisclosureSEC source: 0001225208-23-002660 · doc4.xml · nonDerivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,358 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 4,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002660 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,288 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 8,504 | $0.00 Strike: $206.16 | $0.00 |
DisclosureSEC source: 0001225208-23-001887 · doc4.xml · derivative · entry 2 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,504 Underlying: Common Stock · 8,504 shares Expires 2033-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001887 · doc4.xml · nonDerivative · entry 1 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,721 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,765 | $166.98 | $461,694.17 |
DisclosureSEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 6 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,042 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022. F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $166.32 to $167.27, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,540 | $165.43 | $420,184.07 |
DisclosureSEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 5 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,807 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $165.00 to $165.93, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,135 | $164.59 | $351,392.60 |
DisclosureSEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 4 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,347 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $163.955 to $164.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 20:12 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 567 | $167.69 | $95,078.87 |
DisclosureSEC source: 0001225208-22-011214 · doc4.xml · nonDerivative · entry 3 KELLEY JOHN J III · CIK 0001562224 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,482 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/24/2022. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $167.43 to $167.92, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.